Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review

With a globally estimated 58 million people affected by, chronic hepatitis C virus (HCV) infection still represents a hard challenge for scientific community. A chronic course can occur among patients with a weak innate ad adaptive response with cirrhosis and malignancies as main consequences. Oncol...

Descripción completa

Detalles Bibliográficos
Autor principal: Spera, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055195/
https://www.ncbi.nlm.nih.gov/pubmed/35582286
http://dx.doi.org/10.4254/wjh.v14.i3.525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055195/
https://www.ncbi.nlm.nih.gov/pubmed/35582286
http://dx.doi.org/10.4254/wjh.v14.i3.525

Ejemplares similares